Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Asieris, Beigene, Biomebank, Biontech, Brexogen, GSK, J Ints, Moderna, Novavax, Pfizer, Sanofi, Sinovac, Swedish Orphan Biovitrum, Takeda, YS.